Global Stable Isotope Labeled Compounds Market

1 INTRODUCTION OF GLOBAL STABLE ISOTOPE LABELED COMPOUNDSMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL STABLE ISOTOPE LABELED COMPOUNDSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END USER:
5.1 Pharmaceutical and Biotechnology Companies
5.2 Academic & Research Institutes
5.3 Hospitals and Diagnostic Centers
5.3.1 Other End Users

6 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY APPLICATION:
6.1 Research
6.1.1 Biomedical Research
6.1.2 Pharmaceutical Research
6.1.3 Environmental & Ecological Research
6.1.4 Agricultural Research
6.2 Clinical Diagnostics
6.3 Industrial
6.4 Other Applications

7 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE:
7.1 Deuterium
7.2 Carbon-13
7.3 Oxygen-18
7.4 Nitrogen-15
7.5 Other Stable Isotopes

8 GLOBAL STABLE ISOTOPE LABELED COMPOUNDSMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

9 GLOBAL STABLE ISOTOPE LABELED COMPOUNDSMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Cambridge Isotope Laboratories, Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Merck KGaA
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Urenco Limited
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Isosciences, LLC (An Mdp Chemicals Company)
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Medical Isotopes, Inc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Omicron Biochemicals, Inc.
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Nordion (Canada) Inc. (A Sterigenics International LLC Company)
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Trace Sciences International
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Alsachim
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development

10.10 Taiyo Nippon Sanso Corporation
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development

10.11 Perkinelmer Inc.
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Development

10.12 Rotem Industries Israel Ltd
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Development

11 Appendix
11.1 Related Reports